Scientists detail link between molnupiravir and SARS-CoV-2 mutations (By: Lisa Schnirring)
A new paper suggests scientists are worried about molnupiravir's capacity to trigger SARS-CoV-2 mutations, echoing concerns that were raised even before countries approved it for emergency use in late 2021 as the Omicron variant arrived…









